{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-26-000017","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2026-06-23T21:10:03+00:00","discovered_at":"2026-06-23T21:12:00.264509+00:00","generated_at":"2026-06-23T21:12:44.786367+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"medium","headline":"Kewaunee Scientific reports FY2026 revenue up 17.3% to $282M; EPS down to $3.22 from $3.83","bullets":["Full-year sales $281.999M (+17.3% YoY); net earnings $9.618M vs $11.405M prior year.","Diluted EPS $3.22 compared to $3.83; EBITDA $22.425M vs $21.613M.","Lab Products Group segment sales $214.886M (+19.8%), net earnings $14.156M vs $15.370M.","Company cites challenging market conditions including tariff costs, partly offset by productivity gains.","Nu Aire integration and balance sheet improvement noted as positives."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-26-000017","json":"https://secwatch.observer/filing/0000055529-26-000017.json","markdown":"https://secwatch.observer/filing/0000055529-26-000017.md","text":"https://secwatch.observer/filing/0000055529-26-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552926000017/0000055529-26-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552926000017/kequ-20260623.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:12:44.786367+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}